Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

This study has been completed.
Sponsor:
Information provided by:
Ceragenix Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00460083
First received: April 11, 2007
Last updated: February 5, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)